Kolexia
Leyronnas Cecile Oncologie médicale
Leyronnas Cecile
Oncologie médicale
Groupe Hospitalier Mutualiste de Grenoble
Grenoble, France
51 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Myélome multiple Leucémies Neuropathies périphériques Tumeurs colorectales Leucémie prolymphocytaire à cellules T Amyloïdose Leucémie prolymphocytaire

Collaborateurs

Voir plus
Algrin Caroline
Algrin Caroline
Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France
Lancry-Lecomte Laurence
Lancry-Lecomte Laurence
Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France
Garnier-Tixidre Claire
Garnier-Tixidre Claire
Selarl Institut De Cancerologie De Provence, Aix-en-Provence, France
Fric Daniele
Fric Daniele
Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France

Industries

Voir plus
Janssen
5 collaboration(s)
Dernière en 2023
Lilly
4 collaboration(s)
Dernière en 2023
Pfizer
3 collaboration(s)
Dernière en 2023
Grünenthal
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
IsAMYP: A Phase 2, Open Label, Multicenter, Single-stage Study to Evaluate the Efficacy of Isatuximab Plus Pomalidomide and Dexamethasone (IPd), in Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
Essai Clinique (BMS)   05 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort.
Blood advances   24 octobre 2023
ABLE02: A National, Multicenter, Randomized Controlled Trial to Assess the Efficacy of a Physical Activity Program to Improve Quality of Life and Reduce Fatigue in Women With Metastatic Breast Cancer
Essai Clinique (Centre Léon-Bérard)   29 août 2023
Quality of life and response shift effect of diffuse large B-cell lymphoma French patients included in prospective real-life REALYSA cohort in the first year after diagnosis
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
American journal of hematology   01 janvier 2023
A Phase 2 Single-Arm Study to Evaluate the Efficacy of Isatuximab, Pomalidomide and Low-Dose Dexamethasone, in Patients with AL Amyloidosis Not in VGPR or Better after Any Previous Therapy (IsAMYP)
Annual Meeting Abstracts 2022   15 novembre 2022
BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.
Blood   03 décembre 2021
Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients' Profiles With Oxaliplatin-Induced Peripheral Neuropathy.
Frontiers in pharmacology   04 novembre 2021
Prognostic Impact of 18F-FDG PET/CT in Patients With Aggressive B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T Cells.
Clinical nuclear medicine   08 juillet 2021